Results 241 to 250 of about 158,455 (262)

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

Lancet, The, 2009
Vivek Y Reddy
exaly  

Discussion forum: ‘left atrial phasic function terminology’

European Heart Journal - Cardiovascular Imaging
Järvinen Vesa, Järvinen Vesa
openaire   +2 more sources

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Lancet, The, 2003
Jan Östergren, Karl Swedberg, Christopher B Granger   +2 more
exaly  

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Lancet, The, 2008
Kim Fox, Philippe Gabriel Steg, Michal Tendera   +2 more
exaly  

Left ventricular non-compaction cardiomyopathy

Lancet, The, 2015
Jeffrey A Towbin, Angela Lorts
exaly  

False equivalencies: Online activism from left to right

Science, 2020
Deen Freelon, Alice Marwick
exaly  

Left Atrial Function and Sudden Cardiac Death

Canadian Journal of Cardiology, 2019
David, Lee, Ratika, Parkash
openaire   +2 more sources

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

Lancet, The, 2008
Kim Fox, Philippe Gabriel Steg, Michal Tendera   +2 more
exaly  

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

Lancet, The, 2006
Gilles R Dagenais, Janice Pogue, Salim Yusuf   +2 more
exaly